Task: Please create a description for a molecule.
SMILES: CC[C@H](C)Nc1nc(N)nc2c1ncn2[C@H]1C=C[C@@H](CO)C1
Constraint: Answer the question with full sentences.
Result: The molecule is a 2,6-diaminopurine that is an analogue of abacavir in which the cyclopropylamino group at position 6 of the purine moiety is replaced by an (S)-sec-butylamino group. One of a series of synthesised abacavir analogues with antiviral activity found to stimulate IFN-gamma secretion in abacavir-responsive clones. It has a role as an antiviral agent. It derives from an abacavir.
Task: Please create a {#text |!}description for a molecule{# based on its representation|!}.
{#Molecule |!}{SMILES__description}: {SMILES#}
Constraint: Answer the question with {#full|complete!} sentences.
Result: {description#}
CC[C@H](C)Nc1nc(N)nc2c1ncn2[C@H]1C=C[C@@H](CO)C1
[(1S,4R)-4-[2-amino-6-[[(2S)-butan-2-yl]amino]purin-9-yl]cyclopent-2-en-1-yl]methanol
The molecule is a 2,6-diaminopurine that is an analogue of abacavir in which the cyclopropylamino group at position 6 of the purine moiety is replaced by an (S)-sec-butylamino group. One of a series of synthesised abacavir analogues with antiviral activity found to stimulate IFN-gamma secretion in abacavir-responsive clones. It has a role as an antiviral agent. It derives from an abacavir.